Replies to post #4414 on Biotech Values

[randychub]

Why would you think they would not allow this as a prescription? There are certainly more harmful drugs already on the market. Also even if they have to come into the office it still is a preferred delivery.

"I rather doubt the FDA would approve self-administration of an AMD drug that is not a pill, and hence I found Levitt’s comment about a subcutaneous formulation odd to say the least"

Thanks,

R

[swampboots]

"As for the dosing schedule of the existing IV formulation, anything more frequent than monthly is too frequent, IMHO. During the initial four-week loading-dose period, it’s reasonable to expect patients to come into the clinic weekly. But it’s not reasonable to expect patients to continue to come in weekly, or even bi-weekly, for treatment after treatment."

Absolute knowledge rearding the above will only be proven by actual experience. However, I suspect that if a patient knew anything about AMD from their experience with another family member or friend or even from third part gossip, that person so stricken with AMD would be likely to contemplate bi- weekly visits with glee. Such a motivated reaction would be the consequence of having realized his possible fortunate circumstance in locating a treatment which has every liklihood of warding off a devestating irreversable affliction.